Latest news
HORIZON-Breast01: Trastuzumab Rezetecan Delivers 30.6-Month PFS - OncodailyOncodaily · Wed, 05 Aug 2026 16:39:20 GMTPirtobrutinib Combo Boosts PFS in Previously Treated CLL/SLL - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 14:38:54 GMTRucaparib plus nivolumab maintenance did not meet 4-month PFS target in advanced biliary tract cancer - Vera HealthVera Health · Sun, 02 Aug 2026 09:15:29 GMTAtezolizumab Plus Chemotherapy Improves PFS in dMMR/MSI-H Metastatic CRC - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 15:37:19 GMT